GRANULOSA CELL TUMOUR OF THE TESTIS

This adverse event was reported 7 times

GRANULOSA CELL TUMOUR OF THE TESTIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SUMATRIPTAN SUCCINATE 6 0.0002
1 RIZATRIPTAN BENZOATE 2 0.0002
2 SUMATRIPTAN 6 0.0002
3 BLEOMYCIN SULFATE 1 0.0001
4 IBUPFROFEN 6 0.0000
5 IBUPROFEN TABLETS USP, 200MG 6 0.0000
6 IBUPROFEN ORAL 6 0.0000
7 IBUPROFEN CAPSULES 200 MG 6 0.0000
8 AZITHROMYCIN MONOHYDRATE 1 0.0000
9 IBUPROFEN 6 0.0000
See all drugs enriched for association with GRANULOSA CELL TUMOUR OF THE TESTIS

GRANULOSA CELL TUMOUR OF THE TESTIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] 6 0.0002
1 Topoisomerase Inhibitor [EPC] 1 0.0000
2 Aromatase Inhibitor [EPC] 1 0.0000
3 Microtubule Inhibitor [EPC] 1 0.0000
4 Nonsteroidal Anti-inflammatory Drug [EPC] 6 0.0000
5 Platinum-based Drug [EPC] 1 0.0000
See all drug classes enriched for association with GRANULOSA CELL TUMOUR OF THE TESTIS